CN
93-92-5
Applied Filters:
Keyword:'93-92-5'
Showing 1-30 of 257 results for "93-92-5" within Technical Documents
The Effective Use of Protein Kinase Inhibitors
96 72 71 79 93 106
56 103 13 5 2 62 39 19 92 88 40 92 98 55 57 93 94 51 74 88 59 14
96 85 102 101 76 50 58 77 87 76
The Effective Use of Protein Kinase Inhibitors
96 72 71 79 93 106
56 103 13 5 2 62 39 19 92 88 40 92 98 55 57 93 94 51 74 88 59 14
96 85 102 101 76 50 58 77 87 76
High throughput sample preparation for the quantitation of drug compounds in serum samples
Deviation
Digoxin 97% 7% 91% 3%
Propranolol 94% 5% 91% 4%
Taxol 93% 5% 93% 4%
Testosterone 101% 5% 93% 4%
Verapamil 95% 6% 96% 5%
Warfarin 92% 4% 87% 4%
Development of Multiplex Immunoassay Panels for Simultaneous Quantification of Bone Metabolism Markers using Luminex xMAP Technology
%):
1A 1B 2A 2B
RANKL — — 119 78
OPG 95 90 — —
Insulin 92 101 92 91
Leptin 87 93 93 93
ACTH 117 92 115 85
IL-6 86 87 89 90
TNFα 122 92 133 93
Osteocalcin — 99 — 97
PRECISION:
Intra-assay <4%
Inter-assay
Product Information Sheet - 80476
Page 3 of 5
Figure 2: Product Drawing
DUO +34 deg C
Run-Time acceleration with temp
Data Sheet - H161
METHYLENEDIOXYAMPHETAMINE
(±)-N-HYDROXY MDA
>93% purity
CNS stimulant; hallucinogen.
Mol. Formula: C10H13NO3
Mol. Wt.: 195.22 (anhyd.)
m.p.: 92-93°C
CAS Registry No.: 114562-59-3
Chemical
RABBIT ANTI-VESICULAR MONOAMINE TRANSPORTER 2 AFFINITY PURIFIED
PNAS (1995) 92:8773-8777.
3) J. Cell Biol. (1994) 127:1419-1433.
4) FEBS Lett. (1993) 318:325-330; J Neurochem. (1993) 61:2314-2317.
5) J. Neurosci. (1996) 16:4135-4145.
6) PNAS (1996) 93:5166-5171
DECLARATION OF CONFORMITY Benchmark MyBlock Digital Drybath
010:92
EN 55011:98/A1:99/A2:02
EN 61000-3-2:00+A2:05
EN 61000-3-3:95+A1:01+A2:05
EN 61000-4-2:95 +A1:98 +A2:01
EN 61000-4-3:02 +A1:02
EN 61000-4-4:04
Data Sheet - SAB4200884
Hassett DJ., J Bacteriol., 178, 7322–5 (1996).
3. Mulcahy LR., et al., Microb Ecol., 68, (2014).
4. Smith EE., et al., P Natl Acad Sci USA., 103,
8487–92 (2006).
5. Sadikot RT., et al., Am J Respir
Data Sheet - SAB4200866
Hassett DJ., J Bacteriol., 178: 7322–5 (1996).
3. Mulcahy LR., et al., Microb Ecol., 68: (2014).
4. Smith EE., et al., P Natl Acad Sci USA., 103:
8487–92 (2006).
5. Sadikot RT., et al.
DECLARATION OF CONFORMITY -Benchmark MultiTherm Shaker
010:92
EN 55011:98/A1:99/A2:02
EN 61000-3-2:00+A2:05
EN 61000-3-3:95+A1:01+A2:05
EN 61000-4-2:95 +A1:98 +A2:01
EN 61000-4-3:02 +A1:02
EN 61000-4-4:04
LABORATORY NOTEBOOK ISSUANCE PAGE
)
58
.6
93
63
.5
46
65
.3
8
10
6.
42
10
7.
87
11
2.
41
19
5.
08
19
6.
97
20
0.
59
(2
81
)
(2
80
)
(2
85
LABORATORY NOTEBOOK ISSUANCE PAGE
)
58
.6
93
63
.5
46
65
.3
8
10
6.
42
10
7.
87
11
2.
41
19
5.
08
19
6.
97
20
0.
59
(2
81
)
(2
80
)
(2
85
LABORATORY NOTEBOOK ISSUANCE PAGE
)
58
.6
93
63
.5
46
65
.3
8
10
6.
42
10
7.
87
11
2.
41
19
5.
08
19
6.
97
20
0.
59
(2
81
)
(2
80
)
(2
85
Data Sheet - 78830
faint yellow powder
Molecular weight: 174.2 g/mol
Molecular Formula: C7H7FO2S
Melting Point: 92-93°C
Store at room temperature
PMSF is an inhibitor of serine proteases and acetylcholinesterase
Data Sheet - N9161
, et al., Proc. Natl. Acad. Sci. USA,
93, 13014-13019 (1996).
5. Huppert, S.S., et al., Nature, 405, 966-970
(2000).
6. Milner, L.A., et al., Blood, 93, 243-248 (1999).
Data Sheet - M7931
Acad. Sci. USA, 93, 9997
(1996).
4. Romanowski, P., et al., Proc. Natl. Acad. Sci. USA,
93, 10189 (1996).
5. Dalton, S., and Whitbread, L., Proc. Natl. Acad. Sci.
USA, 92, 2514 (1995).
6
Quality Control Range Sheet- A60MG-104 and A60MG-204
1 22 - 46 pg/mL IL-18 Control1 17 – 36 pg/ml
Control 2 109 - 227 pg/mL Control 2 92 - 192 pg/ml
IL-5 Control 1 25
Verfication summary-03-0202-00
HMN713786
3 MRD (1:4) 35.58 1.0 3% 142.31 4.2 3% -
3 1:8 16.42 0.9 5% 131.35 6.9 5% 92%
3 1:16 8.17 0.4 5% 130.65 6.1 5% 92%
3 1:32 4.69 0.2 4% 150.01 5.8 4% 105%
Verfication summary-03-0202-00
HMN713786
3 MRD (1:4) 35.58 1.0 3% 142.31 4.2 3% -
3 1:8 16.42 0.9 5% 131.35 6.9 5% 92%
3 1:16 8.17 0.4 5% 130.65 6.1 5% 92%
3 1:32 4.69 0.2 4% 150.01 5.8 4% 105%
SARS-Cov2 anti-RBD IgG ELISA
14.0 13.5 96%
25 7.0 6.4 92%
12.5 3.5 3.2 92%
4 100 27.2 27.2
50 13.6 12.6
Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel
212 pg/mL sCD40L Control 1 93 – 193 pg/mL
Control 2 515 – 1070 pg/mL Control 2 471 – 977 pg/mL
Data Sheet - M9570
Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H., et al
Data Sheet - M5427
Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H., et al
Data Sheet - C9979
Acad. Sci. USA,
93, 7838 (1996).
3. Gribben, J.G., et al., Proc. Natl. Acad. Sci. USA,
92, 811 (1995).
4. Karandikar, N.J., et al., J. Exp. Med., 184, 783
(1996).
5. Walunas, T.L., et
Product Information Sheet - SE120011
Red White Port Sherry Must Juice Beer
Wine Wine
0.02 93 85 100 105 98 65 120
0.05 104 98 102 104 101 72
Data Sheet - R7898
specifically reacts with human B-Raf (98 kD)
and with several other molecular weight bands (38 kD,
92 kD and 116 kD) but not Raf-A or Raf-1. It is thought
that additional bands are either degradation products
Data Sheet - T9951
, Proc. Natl. Acad. Sci. USA, 92,
8125-8129 (1995).
2. Jungbluth, A.A., et al., Pathol. Res. Pract., 196,
235-242 (2000).
3. Greggio, E., et al., J. Neurochem., 93, 246-256
(2005).
4. Clarkson
Quality Control Range Sheet- TH17-112 and TH17-212
- 2.5 ng/mL
Control 2 839 - 1743 pg/mL Control 2 8.1 - 17 ng/mL
IL-15 Control 1 44 - 92 pg/mL IL-27 Control 1 0.61 -
Data Sheet - M9555
., Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
(1997).
6. Birkedal-Hansen, H., et al.
Page 1 of 9